Another AR-bypass pathway is the activation of the AKT-mTOR pathway by p66Shc, which is an oxidase previously shown to promote androgen-independent cell growth through generation of reactive oxygen species (ROS) and being elevated in PCa tumor samples. The gene discussed is AKT1; the disease is neoplasm.